C&y Pharmaceutical (300254.SZ) traded flat 0 % during a 24 hours period ending at 05:18 PM Central Europe on Monday 26th. One C&y Pharmaceutical stock can currently be bought for about CNY 8.1 on popular exchanges. Current supply of C&y Pharmaceutical stocks is 257.7 mn. C&y Pharmaceutical has a current market capitalization of CNY 2.1 bn and approximately CNY 93 mn worth of C&y Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, C&y Pharmaceutical has traded -8.36 % down. Simple moving average of last 200 days is at CNY 8.77. The highest price of past 52 weeks was recorded at CNY 15.2 on 05/11/2026. 52 weeks low was at CNY 6.93 on 07/21/2026.
Here is how related stocks have performed in the past 24 hours:
Beijing Century Real Techn (300150.SZ) traded flat 0 % and now trades at CNY 4.28. Beijing Century Real Techn has a market capitalisation of CNY 2.5 bn. Beijing Century Real Techn has a current price to earnings ratio of 287.84.
Shgf (001205.SZ) traded flat 0 % and now trades at CNY 13.43. Shgf has a market capitalisation of CNY 2.5 bn. Shgf has a current price to earnings ratio of 21.91.
Tyyl (301097.SZ) traded flat 0 % and now trades at CNY 33.87. Current market capitalisation for Tyyl is CNY 2.5 bn. TYYL, a Chinese medical‑device manufacturer, reported a strong third‑quarter earnings release that highlighted significant growth in both revenue and profit. The company’s consolidated sales rose noticeably, driven by an expanded product portfolio and a surge in critical‑care services. Earnings per share climbed, and the company noted that operating expenses were kept in check, contributing to a sharp rise in net profit. While the cash‑flow statement turned negative for the quarter, management attributed the shift to increased working‑capital requirements associated with the expansion. The release also detailed ongoing progress in obtaining regulatory approvals for several new device classes, underscoring TYYL’s focus on product development and market expansion. In the market, the company’s shares moved upward modestly, joining a group of peers in the medical‑device sector that experienced a brief rally earlier in the day.
Impact Therapeutics -H (7630.HK) traded up 0.19 % and now trades at HKD 10.85. Current market capitalisation for Impact Therapeutics -H is HKD 2.9 bn.
Yidu Tech (0EL.F) traded flat 0 % and now trades at HKD 2.89. Yidu Tech has a market capitalisation of HKD 2.9 bn. Yidu Tech has a current price to earnings ratio of 55.17.